Live from the NIH registry
Studies recruiting near El Paso right now
Top 25 of 190 recruiting studies, sorted by proximity — each links to its official registry page
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
Helicobacter Pylori, Safety
Phase 3
Interventional 40 participants sought
Harmony United Research — El Paso, Texas (7.0 mi)
· Sponsor: ARJ Medical, Inc.
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
Systemic Lupus Erythematosus
Phase 3
Interventional 450 participants sought
Sl0044 50781 — El Paso, Texas (7.0 mi)
· Sponsor: UCB Biopharma SRL
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Advanced Neurology Epilepsy and Sleep Center/ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
Glaucoma
Phase 2
Interventional 110 participants sought
Glaukos Clinical Site — El Paso, Texas (7.0 mi)
· Sponsor: Glaukos Corporation
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
COPD, Smoking
N/A
Interventional 290 participants sought
El Paso Pulmonary Association — El Paso, Texas (7.0 mi)
· Sponsor: Philip Morris Products S.A.
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults
Chronic Idiopathic Constipation (CIC)
Phase 3
Interventional 692 participants sought
3A Research — El Paso, Texas (7.0 mi)
· Sponsor: Ardelyx
Improving Glycemic Control With Electrical Stimulation
Obesity, Overweight
N/A
Interventional 60 participants sought
University of Texas at El Paso — El Paso, Texas (7.0 mi)
· Sponsor: University of Texas, El Paso
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: National Cancer Institute (NCI)
AngelMed Guardian® System PMA Post Approval Study
Acute Coronary Syndrome
N/A
Observational 500 participants sought
Texan Cardiovascular Institute — El Paso, Texas (7.0 mi)
· Sponsor: Angel Medical Systems
Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
Migraine
EARLY/Phase 1
Interventional 84 participants sought
University Medical Center of El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Texas Tech University Health Sciences Center, El Paso
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Academy of Diabetes, Thyroid and Endocrine /ID# 255735 — El Paso, Texas (7.0 mi)
· Sponsor: AbbVie
A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
Systemic Lupus Erythematosus (SLE)
N/A
Observational 223 participants sought
El Paso Medical Research Institute (MedResearch, Inc) — El Paso, Texas (7.0 mi)
· Sponsor: Bristol-Myers Squibb
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
Pulmonary Disease, Chronic Obstructive
Phase 3
Interventional 961 participants sought
GSK Investigational Site — El Paso, Texas (7.0 mi)
· Sponsor: GlaxoSmithKline
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Phase 2, Phase 3
Interventional 590 participants sought
Local Institution - 0374 — El Paso, Texas (7.0 mi)
· Sponsor: Bristol-Myers Squibb
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Idiopathic Pulmonary Fibrosis (IPF)
Phase 2
Interventional 359 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
rTMS for Military TBI-related Depression
Depressive Symptoms, Mild Traumatic Brain Injury
N/A
Interventional 198 participants sought
William Beaumont Army Medical Center — Fort Bliss, Texas (2.6 mi)
· Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
Systemic Lupus Erythematosus
Phase 3
Interventional 100 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Generalized Myasthenia Gravis
Phase 3
Interventional 264 participants sought
ANESC Research — El Paso, Texas (7.0 mi)
· Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
Phase 3
Interventional 11,300 participants sought
Research Site — El Paso, Texas (7.0 mi)
· Sponsor: AstraZeneca
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
Metastatic Malignant Neoplasm in the Lung, Metastatic Osteosarcoma
Phase 3
Interventional 62 participants sought
El Paso Children's Hospital — El Paso, Texas (7.0 mi)
· Sponsor: Children's Oncology Group
Gastroparesis Registry 4
Gastroparesis, Gastroparesis Nondiabetic
N/A
Observational 250 participants sought
Texas Tech University Health Science Center (TTUHSC) — El Paso, Texas (7.0 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
Moderately to Severely Active Crohns Disease
Phase 3
Interventional 600 participants sought
Proactive El Paso,LLC — El Paso, Texas (7.0 mi)
· Sponsor: Hoffmann-La Roche
Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia
Hypertriglyceridemia
Phase 3
Interventional 869 participants sought
Research Site 27 — El Paso, Texas (7.0 mi)
· Sponsor: Arrowhead Pharmaceuticals
Depth of Maximal Ileal Insertion During Retrograde Enteroscopy With TTS Balloon
Obscure Gastrointestinal Bleeding, Anemia, Iron Deficiency
N/A
Observational 100 participants sought
Texas Tech University Health Science Center El Paso — El Paso, Texas (7.0 mi)
· Sponsor: Texas Tech University Health Sciences Center, El Paso
RA-PRO PRAGMATIC TRIAL
Rheumatoid Arthritis
Phase 3
Interventional 924 participants sought
Texas Arthritis Center, PA — El Paso, Texas (7.0 mi)
· Sponsor: University of Alabama at Birmingham